Mount Sinai Queens is a clinical research site located in Astoria, New York, United States 11102.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Mount Sinai Queens has participated in 6 clinical trials with 5 currently active.
Therapeutic areas: Stage I Breast Cancer, SARS-CoV2 Infection, Advanced Heart Failure.
Sponsors: NRG Oncology, Gilead Sciences, Icahn School of Medicine at Mount Sinai.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Mount Sinai Queens has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mount Sinai Queens has 6 clinical trials on record, with 5 currently active. Their work covers Stage I Breast Cancer, SARS-CoV2 Infection, Advanced Heart Failure.
Yes — Mount Sinai Queens holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.